Pharmacology of Chemotherapy
Although maximum new capsules for most cancers are marketers that focus on molecular adjustments that arise in tumors chemotherapy nonetheless presents the spine of drug remedy for maximum kinds of most cancers. Chemotherapy is used generally to deal with humans with metastatic most cancers, and for lots not unusualplace kinds of person most cancers can offer palliation both via way of means of prolonging survival and/or via way of means of enhancing exceptional of life. Chemotherapy also are used both earlier than or after surgical operation humans with out overt unfold of disease, and might then enhance the chance of therapy via way of means of removing undetectable micrometastases.
Pharmacokinetics is the look at of the time path of drug and metabolite stages in unique frame fluids and tissues, such as absorption, distribution, metabolism, and elimination. Alterations in pharmacokinetic residences of a drug can also additionally bring about unique drug concentrations over the years in unique tissues. Absolute bioavailability refers to the quantity of a drug this is to be had after oral management as compared to that once intravenous management, while relative bioavailability is the quantity of a drug this is to be had from one system relative to that from any other nonintravenous system
- Pharmacokinetics and Pharmacodynamics
- Basics of chemotherapeutic agents action
- Basics of chemotherapy
- Common adverse effects of chemotherapy
- Overview of chemotherapeutic drugs classes
- What are the advantages and disadvantages of oral chemotherapy drugs?
Related Conference of Pharmacology of Chemotherapy
Pharmacology of Chemotherapy Conference Speakers
Recommended Sessions
- Acute and Chronic Lymphocytic Leukemia
- Bone Marrow Transplantation
- Development of Hematopoietic Progenitor and Stem Cells
- Digital imaging in Hematology
- Disorders of Vascular Bleeding
- Epigenetic Mechanisms: Emerging Therapeutic Targets for Blood Disorders
- Genetics, Genomics, and Epigenetics
- Genome Editing and Cellular Therapy
- Hematologic Malignancy
- Hematology and Covid-19
- Hematology-Oncology
- Hemoglobin and Iron Metabolism
- Hemoglobinopathies
- Hemophilia
- Hemostasis and Thrombosis
- Immunology and Immunotherapies
- Multiple Myeloma and Other Plasma Cell Disorders
- Myelodysplastic and Myeloproliferative Disorders
- Pediatric Hematology
- Pharmacology of Chemotherapy
- Radiation Oncology or Cancer Therapy
- Transfusion Medicine
- Types of Blood Disorders
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (Italy)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (Italy)
- Blood Disorders and the Immune System - Blood Disorders 2025 (Italy)
- Blood Disorders Diagnosis & Treatment - HEMATOLOGY 2025 (Spain)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (Italy)
- Blood Transfusion - HEMATOLOGY 2025 (Spain)
- Case reports of Hematology - HEMATOLOGY 2025 (Spain)
- CellTherapy - HEMATOLOGY 2025 (Spain)
- COVID-19 and Hematology - HEMATOLOGY 2025 (Spain)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (Italy)
- Disorders of Vascular Bleeding - HEMATOLOGY 2025 (Spain)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (Italy)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (Italy)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (Italy)
- Hematology - HEMATOLOGY 2025 (Spain)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (Italy)
- Hematology Oncology - HEMATOLOGY 2025 (Spain)
- Immunohematology - HEMATOLOGY 2025 (Spain)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (Italy)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (Italy)
- Leukaemia and Lymphoma - HEMATOLOGY 2025 (Spain)
- Multiple Myeloma, Amyloidosis, and Stem Cell Transplantation - HEMATOLOGY 2025 (Spain)
- New Drug Development in Hematology - HEMATOLOGY 2025 (Spain)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (Italy)
- Patient Blood Management - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (Italy)
- Stem Cell Research - HEMATOLOGY 2025 (Spain)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (Italy)
- Thalassemia - HEMATOLOGY 2025 (Spain)
- Therapeutic Apheresis - HEMATOLOGY 2025 (Spain)
- Thrombosis and Coagulation - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (Italy)
- Transfusion Transmissible Infections - HEMATOLOGY 2025 (Spain)